Shanghai - Delayed Quote CNY

Shanghai Runda Medical Technology Co., Ltd. (603108.SS)

17.79 -0.31 (-1.71%)
At close: 3:00 PM GMT+8
Loading Chart for 603108.SS
DELL
  • Previous Close 18.10
  • Open 17.96
  • Bid 17.79 x --
  • Ask 17.80 x --
  • Day's Range 17.71 - 18.25
  • 52 Week Range 11.20 - 27.70
  • Volume 20,097,454
  • Avg. Volume 37,973,748
  • Market Cap (intraday) 10.654B
  • Beta (5Y Monthly) 0.39
  • PE Ratio (TTM) 26.95
  • EPS (TTM) 0.66
  • Earnings Date --
  • Forward Dividend & Yield 0.15 (0.83%)
  • Ex-Dividend Date Jul 18, 2023
  • 1y Target Est --

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.

www.rundamedical.com

3,499

Full Time Employees

December 31

Fiscal Year Ends

Related News

Performance Overview: 603108.SS

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

603108.SS
12.58%
SSE Composite Index
2.62%

1-Year Return

603108.SS
38.32%
SSE Composite Index
6.79%

3-Year Return

603108.SS
53.63%
SSE Composite Index
12.13%

5-Year Return

603108.SS
45.74%
SSE Composite Index
4.64%

Compare To: 603108.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603108.SS

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    10.84B

  • Enterprise Value

    16.83B

  • Trailing P/E

    27.42

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.11

  • Price/Book (mrq)

    2.66

  • Enterprise Value/Revenue

    1.73

  • Enterprise Value/EBITDA

    15.63

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.05%

  • Return on Assets (ttm)

    3.51%

  • Return on Equity (ttm)

    11.08%

  • Revenue (ttm)

    9.75B

  • Net Income Avi to Common (ttm)

    395.16M

  • Diluted EPS (ttm)

    0.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.03B

  • Total Debt/Equity (mrq)

    134.23%

  • Levered Free Cash Flow (ttm)

    -38.95M

Research Analysis: 603108.SS

Analyst Price Targets

 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: 603108.SS

People Also Watch